Theodore R. Schroeder
Net Worth
Last updated:
What is Theodore R. Schroeder net worth?
The estimated net worth of Mr. Theodore R. Schroeder is at least $5,104,920 as of 11 Aug 2022. He has received compensation worth at least $5,104,920 in Nabriva Therapeutics plc.
What is the salary of Theodore R. Schroeder?
Mr. Theodore R. Schroeder salary is $850,820 per year as Chief Executive Officer & Director in Nabriva Therapeutics plc.
How old is Theodore R. Schroeder?
Mr. Theodore R. Schroeder is 70 years old, born in 1955.
What stocks does Theodore R. Schroeder currently own?
As insider, Mr. Theodore R. Schroeder owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Nabriva Therapeutics plc (NBRV) | Chief Executive Officer & Director | 325,879 | $0 | $0 |
What does Nabriva Therapeutics plc do?
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.
Theodore R. Schroeder insider trading
Nabriva Therapeutics plc
Nabriva Therapeutics key executives
Nabriva Therapeutics plc executives and other stock owners filed with the SEC:
- Dr. Colin Broom M.D. (69) Director
- Dr. Steven P. Gelone Pharm. D (57) Pres, Chief Operating Officer & Director
- Mr. Theodore R. Schroeder (70) Chief Executive Officer & Director